TOKYO – China Resources Pharmaceutical Group (CR Pharma) launched an IPO roadshow in Hong Kong as it looks to raise as much as $2 billion in capital. The company is a part of China Resources Holdings, a state-owned Chinese conglomerate with a wide distribution network across the world's most populous nation.
TOKYO – China Resources Pharmaceutical Group (CR Pharma) launched an IPO roadshow in Hong Kong as it looks to raise as much as $2 billion in capital. The company is a part of China Resources Holdings, a state-owned Chinese conglomerate with a wide distribution network across the world's most populous nation.
TOKYO – Japan's Daiichi Sankyo Co. Ltd. is making progress in the oncology field, a key sector for social well-being as the global population grows older.
TOKYO – Japan’s Daiichi Sankyo Co. Ltd. is making progress in the oncology field, a key sector for social well-being as the global population grows older.
TOKYO – India's Sun Pharmaceutical Industries Ltd. will be heading to Japan to sell generics and biosimilars in partnership with Mitsubishi Tanabe Pharma Corp., beginning in November.
TOKYO – India's Sun Pharmaceutical Industries Ltd. will be heading to Japan to sell generics and biosimilars in partnership with Mitsubishi Tanabe Pharma Corp., beginning in November.
TOKYO – The Japanese government said a letter it wrote to the EU and Britain expressing trepidation about the future of the region after the U.K. voted to leave the union – a decision known as the Brexit – was penned after discussions with companies of all sizes. (See BioWorld Today, Sept. 14, 2016.)
